• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物与肝硬化患者的死亡风险:一项前瞻性队列研究。

Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study.

作者信息

Tabar Mohsen Shaygan, Nilghaz Maryam, Hekmatdoost Azita, Pashayee-Khamene Fereshteh, Mokhtari Zeinab, Karimi Sara, Ahmadzadeh Saleheh, Saberifiroozi Mehdi, Hatami Behzad, Yari Zahra

机构信息

Student Research Committee, Department of Clinical Nutrition and dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Clinical Nutrition and dietetics Department, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Sci Rep. 2025 Feb 8;15(1):4798. doi: 10.1038/s41598-025-89433-y.

DOI:10.1038/s41598-025-89433-y
PMID:39922975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11807124/
Abstract

The role of diet in reducing the burden of liver disease and mortality attributed to cirrhosis is very imperative. The present study scrutinized the relationship between dietary advanced glycation end products (AGEs) and mortality in patients with cirrhosis. This research was a prospective cohort study on 166 ambulatory cirrhotic patients who had been diagnosed with cirrhosis for a maximum of six months. Follow-up of patients continued for 5 years until May 2024. To determine the incidence of mortality in the quartiles of dietary AGEs, cox regression models were used with the adjustment of potential confounding variables. Although the first model of the analysis by adjusting the results for age and sex failed to show a significant increase in the risk of mortality in patients (HR = 2.64; 95% CI = 0.9-7.5, P trend = 0.075), after adjusting the results for further confounders in the second (HR = 3.56; 95% CI = 1.1-11.6, P trend = 0.040) and third (HR = 3.3; 95% CI = 1.79-13.7, P trend = 0.048) models, the P trend for the risk of mortality during the quartiles of AGEs became significant. In addition, along with increasing trend of dietary AGEs, the number of deaths increased significantly (P = 0.024). Higher mortality risk was generally attributed to higher dietary AGEs in patients with cirrhosis.

摘要

饮食在减轻肝病负担及降低肝硬化所致死亡率方面的作用至关重要。本研究仔细审查了饮食晚期糖基化终产物(AGEs)与肝硬化患者死亡率之间的关系。这项研究是一项前瞻性队列研究,对象为166名门诊肝硬化患者,他们被诊断为肝硬化的时间最长为6个月。对患者的随访持续了5年,直至2024年5月。为了确定饮食AGEs四分位数中的死亡率发生率,使用了Cox回归模型,并对潜在的混杂变量进行了调整。尽管在按年龄和性别调整结果后的第一个分析模型中,未显示患者死亡率风险有显著增加(HR = 2.64;95% CI = 0.9 - 7.5,P趋势 = 0.075),但在第二个(HR = 3.56;95% CI = 1.1 - 11.6,P趋势 = 0.040)和第三个(HR = 3.3;95% CI = 1.79 - 13.7,P趋势 = 0.048)模型中对结果进行进一步混杂因素调整后,AGEs四分位数期间死亡率风险的P趋势变得显著。此外,随着饮食AGEs的增加趋势,死亡人数显著增加(P = 0.024)。肝硬化患者较高的死亡率风险通常归因于较高的饮食AGEs。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/838d/11807124/4e8950be961d/41598_2025_89433_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/838d/11807124/4e8950be961d/41598_2025_89433_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/838d/11807124/4e8950be961d/41598_2025_89433_Fig1_HTML.jpg

相似文献

1
Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study.晚期糖基化终末产物与肝硬化患者的死亡风险:一项前瞻性队列研究。
Sci Rep. 2025 Feb 8;15(1):4798. doi: 10.1038/s41598-025-89433-y.
2
Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients.结直肠癌患者诊断前血浆晚期糖基化终产物和可溶性晚期糖基化终产物受体与死亡率的关系。
Int J Cancer. 2024 Dec 1;155(11):1982-1995. doi: 10.1002/ijc.35114. Epub 2024 Jul 26.
3
Dietary glycation compounds - implications for human health.饮食糖化化合物 - 对人类健康的影响。
Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16.
4
Dietary advanced glycation end products intake, genetic predisposition and risk of coronary heart disease: a prospective study.膳食晚期糖基化终产物摄入量、遗传易感性与冠心病风险:一项前瞻性研究。
Eur J Nutr. 2025 Mar 10;64(3):114. doi: 10.1007/s00394-025-03632-x.
5
Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer.膳食中晚期糖基化终产物(AGEs)的摄入量与结直肠癌患者的死亡率。
Nutrients. 2021 Dec 10;13(12):4435. doi: 10.3390/nu13124435.
6
Dietary advanced glycation end products may increase the incidence of allergic rhinitis depending on genetic susceptibility: a prospective cohort study.根据遗传易感性,膳食晚期糖基化终产物可能会增加过敏性鼻炎的发病率:一项前瞻性队列研究。
Food Funct. 2025 May 6;16(9):3604-3612. doi: 10.1039/d4fo05911e.
7
Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.在NIH-AARP饮食与健康前瞻性研究中,晚期糖基化终产物的膳食摄入与胰腺癌的关系。
Am J Clin Nutr. 2015 Jan;101(1):126-34. doi: 10.3945/ajcn.114.098061. Epub 2014 Nov 19.
8
Dietary Approaches to Stop Hypertension (DASH) and mortality risk among patients with liver cirrhosis: a prospective cohort study.膳食限盐对高血压防治(DASH)与肝硬化患者死亡率风险之间的关系:一项前瞻性队列研究。
BMC Res Notes. 2024 Sep 4;17(1):248. doi: 10.1186/s13104-024-06928-z.
9
The association of dietary inflammatory indices and mortality in patients with cirrhosis: a cohort based study.膳食炎症指数与肝硬化患者死亡率的相关性:基于队列的研究。
Sci Rep. 2024 Sep 14;14(1):21472. doi: 10.1038/s41598-024-72485-x.
10
Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.膳食晚期糖基化终产物与欧洲癌症与营养前瞻性调查(EPIC)研究中的结直肠癌风险。
Nutrients. 2021 Sep 8;13(9):3132. doi: 10.3390/nu13093132.

本文引用的文献

1
Dietary acid load and cirrhosis-related mortality: a prospective cohort study.饮食酸负荷与肝硬化相关死亡率:一项前瞻性队列研究。
Sci Rep. 2024 Feb 14;14(1):3675. doi: 10.1038/s41598-024-53882-8.
2
Dietary protein intake and mortality among survivors of liver cirrhosis: a prospective cohort study.肝硬化幸存者的膳食蛋白质摄入量与死亡率:一项前瞻性队列研究。
BMC Gastroenterol. 2023 Jul 3;23(1):227. doi: 10.1186/s12876-023-02832-1.
3
Global epidemiology of cirrhosis - aetiology, trends and predictions.全球肝硬化的流行病学:病因、趋势和预测。
Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28.
4
Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.男性和女性肝癌的全球负担:病因基础的变化及非酒精性脂肪性肝炎(NASH)的贡献日益增加。
Hepatology. 2023 Apr 1;77(4):1150-1163. doi: 10.1002/hep.32758. Epub 2022 Sep 12.
5
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.酒精性肝硬化相关肝细胞癌的发病率:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 May;21(5):1169-1177. doi: 10.1016/j.cgh.2022.06.032. Epub 2022 Aug 5.
6
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.磁共振弹性成像肝硬度值和 MEFIB 指数与非酒精性脂肪性肝病肝脏相关结局的关系:一项个体参与者的系统评价和荟萃分析。
Gastroenterology. 2022 Oct;163(4):1079-1089.e5. doi: 10.1053/j.gastro.2022.06.073. Epub 2022 Jul 2.
7
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.非酒精性脂肪性肝病相关肝细胞癌的临床特征、监测、治疗分配和结局:系统评价和荟萃分析。
Lancet Oncol. 2022 Apr;23(4):521-530. doi: 10.1016/S1470-2045(22)00078-X. Epub 2022 Mar 4.
8
Review article: current and emerging therapies for the management of cirrhosis and its complications.综述文章:肝硬化及其并发症管理的当前及新兴疗法
Aliment Pharmacol Ther. 2022 May;55(9):1099-1115. doi: 10.1111/apt.16831. Epub 2022 Mar 2.
9
Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis.常见非感染性肝病中的晚期糖基化终末产物:系统评价与Meta分析
Nutrients. 2021 Sep 25;13(10):3370. doi: 10.3390/nu13103370.
10
Dietary Advanced Glycation End-Products and Mortality after Breast Cancer in the Women's Health Initiative.膳食晚期糖基化终产物与妇女健康倡议中乳腺癌患者的死亡率。
Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2217-2226. doi: 10.1158/1055-9965.EPI-21-0610. Epub 2021 Sep 28.